BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30709604)

  • 1. Identifying solutions to psychological insulin resistance: An international study.
    Polonsky WH; Fisher L; Hessler D; Stuckey H; Snoek FJ; Tang T; Hermanns N; Mundet X; Silva M; Sturt J; Okazaki K; Hadjiyianni I; Cao D; Ivanova J; Desai U; Perez-Nieves M
    J Diabetes Complications; 2019 Apr; 33(4):307-314. PubMed ID: 30709604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis.
    Stuckey H; Fisher L; Polonsky WH; Hessler D; Snoek FJ; Tang TS; Hermanns N; Mundet-Tuduri X; da Silva MER; Sturt J; Okazaki K; Cao D; Hadjiyianni I; Ivanova JI; Desai U; Perez-Nieves M
    BMJ Open Diabetes Res Care; 2019; 7(1):e000723. PubMed ID: 31908792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes.
    Okazaki K; Shingaki T; Cai Z; Perez-Nieves M; Fisher L
    Diabetes Ther; 2019 Oct; 10(5):1823-1834. PubMed ID: 31286432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study.
    Balogh EG; Perez-Nieves M; Cao D; Hadjiyianni II; Ashraf N; Desai U; Snoek FJ; Sturt JA
    Diabetes Ther; 2020 Aug; 11(8):1735-1744. PubMed ID: 32562245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc).
    Polinski JM; Kim SC; Jiang D; Hassoun A; Shrank WH; Cos X; Rodríguez-Vigil E; Suzuki S; Matsuba I; Seeger JD; Eddings W; Brill G; Curtis BH
    BMC Endocr Disord; 2015 Sep; 15():46. PubMed ID: 26353820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
    Batais MA; Schantter P
    Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
    Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
    Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from Germany.
    Moennig E; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova J; Klask R
    Exp Clin Endocrinol Diabetes; 2018 May; 126(5):287-297. PubMed ID: 28895642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada.
    Tang T; Hessler D; Polonsky WH; Fisher L; Reed B; Irani T; Desai U; Perez-Nieves M
    J Am Board Fam Med; 2020; 33(2):198-210. PubMed ID: 32179603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study.
    Odawara M; Ishii H; Tajima N; Iwamoto Y
    Curr Med Res Opin; 2016; 32(4):681-6. PubMed ID: 26743676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
    Peyrot M; Rubin RR; Lauritzen T; Skovlund SE; Snoek FJ; Matthews DR; Landgraf R; Kleinebreil L;
    Diabetes Care; 2005 Nov; 28(11):2673-9. PubMed ID: 16249538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with psychological insulin resistance in individuals with type 2 diabetes.
    Nam S; Chesla C; Stotts NA; Kroon L; Janson SL
    Diabetes Care; 2010 Aug; 33(8):1747-9. PubMed ID: 20435797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries.
    Lakkis NA; Maalouf GJ; Mahmassani DM; Hamadeh GN
    Fam Pract; 2013 Oct; 30(5):560-7. PubMed ID: 23729488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal insulin persistence in Brazilian participants with T2DM.
    Franco DR; Perez-Nieves M; Ivanova JI; Cao D; Vaz MSC
    Rev Assoc Med Bras (1992); 2019; 65(10):1254-1264. PubMed ID: 31721957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey.
    Munro N; Barnett AH
    Int J Clin Pract; 2014 Jun; 68(6):692-9. PubMed ID: 24548693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.
    Brod M; Alolga SL; Meneghini L
    Patient; 2014; 7(4):437-50. PubMed ID: 24958464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
    Polonsky WH; Fisher L; Guzman S; Villa-Caballero L; Edelman SV
    Diabetes Care; 2005 Oct; 28(10):2543-5. PubMed ID: 16186296
    [No Abstract]   [Full Text] [Related]  

  • 18. What is so tough about self-monitoring of blood glucose? Perceived obstacles among patients with Type 2 diabetes.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabet Med; 2014 Jan; 31(1):40-6. PubMed ID: 23819529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.
    Van Brunt K; Pedersini R; Rooney J; Corrigan SM
    Diabetes Res Clin Pract; 2017 Apr; 126():30-42. PubMed ID: 28189952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.